Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn Limited has submitted copies of its newspaper advertisement published in 'Western Times' (English and Gujarati editions) on May 21, 2025, as required under SEBI Listing Regulations. This is a routine compliance filing confirming that the audited Q4 and FY25 results were published in the newspaper. The published results show Q4 FY25 Total Income from Operations at ₹3,908.38 lakhs and Net Profit after Tax of ₹1,199.81 lakhs. For the full year FY25, Total Income stood at ₹15,323.23 lakhs versus ₹17,418.76 lakhs in FY24 (a decline of about 12%), while Net Profit after Tax was ₹4,877.17 lakhs versus ₹5,916.32 lakhs (a decline of about 17.6%). Basic EPS for FY25 was ₹4.48 versus ₹5.43 in FY24. Equity share capital rose to ₹1,089.65 lakhs from ₹726.44 lakhs.
This filing is a routine regulatory disclosure and does not carry new information beyond what was already filed with the exchanges. However, the underlying results show a clear year-on-year decline in both revenue and profitability, which shareholders and potential investors should factor in when evaluating the stock. No immediate price-moving trigger is expected from this particular filing.